Circulating Neoplastic Cells

Known as: Circulating tumor cells, Cells, Circulating Tumor, Cells, Circulating Neoplastic 
Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
PURPOSE Circulating tumor cells (CTCs) may have utility as surrogate biomarkers and "virtual" biopsies. We report the clinical… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Circulating tumor cell (CTC) number in metastatic cancer patients yields prognostic information consistent with enhanced cell… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PURPOSE Pathologic TNM staging is currently the best prognostic factor for non-small cell lung carcinoma (NSCLC). However, even… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE Persistence of ligand-mediated androgen receptor signaling has been documented in castration-resistant prostate cancers… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE The principal objective of this trial was to evaluate the antitumor activity of abiraterone acetate, an oral, specific… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE It has been postulated that castration-resistant prostate cancer (CRPC) commonly remains hormone dependent. Abiraterone… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND We demonstrated that circulating tumor cell (CTC) number at baseline and follow-up is an independent prognostic factor… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE Circulating tumor cells in blood from metastatic breast cancer patients have been reported as a surrogate marker for… (More)
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE The development of tumor-specific markers to select targeted therapies and to assess clinical outcome remains a… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND We tested the hypothesis that the level of circulating tumor cells can predict survival in metastatic breast cancer… (More)
Is this relevant?